NeutriSci International (NU.V) has completed the research and development required to create a functional beverage using its intellectual property (IP) and technology to enter the cannabidiol beverage market.
“We are excited about the possibilities that this new success brings to the Company. This new industry disrupting capability, coupled with our Technology and IP, is a major milestone for us in the preparation of anticipated B2B orders. We are looking forward to the added revenue potential generated from what the CBD beverage market will bring to the Company. We look forward to sharing more developments on this project as they become available,” commented Glen Rehman, CEO of NeutriSci.
A shift away from carbonated drinks to healthy alternatives is expected to drive the demand for new cannabis beverages. While conventional carbonated drinks contain higher calories and sugar content, light cannabis-infused beverages have increased in popularity. In fact, the global cannabis beverage market is estimated to reach USD$2.8 billion by 2025, growing at a compound annual growth rate (CAGR) of 17.8% from 2019 to 2025, according to Million Insights.
Pacwest Manufacturing, the Company’s manufacturing partner, announced that its bottling line will be fully operational in July 2021. With this in mind, Pacwest’s production capacity exceeding 35,000 per 8-hour shift, will play a pivotal role in producing and showcasing some of NeutriSci’s IPs and technology. Moreover, as COVID-19 restrictions are reduced globally, the Company has restarted some of its previously announced business-to-business (B2B) arrangements. Some of these plans include the potential for CBD beverages to compliment the sublingual melt technology including in some of the Company’s arranged MOUs (memorandum of understanding).
Sublingual refers to the pharmacological route of https://e4njohordzs.exactdn.com/wp-content/uploads/2021/10/tnw8sVO3j-2.pngistration by which substances are diffused through tissues under the tongue. With this in mind, sublingual melt technology simply refers to products that are placed under the tongue. Nothing too complicated about it, however, NeutriSci has made quite a name for itself in Japan by utilizing this technology. In conjunction with its partner, Tabletz, NeutriSci, held an official launch of its TABLETZ products in Japan on November 4th. Since then, the company completed its first large scale purchase order from Japan which consisted of several hundred thousand units of both the 3-tablet and 7-tablet TABLETZ sticks.
For a relatively cheap stock, NeutriSci shows potential as a low-risk small cap investment. NeutriSci’s TABLETZ have been distributed into 46,000 stores throughout Japan, including popular retailers such as 7-Eleven, K.K. and Lawson. With a population of more than 126 million people, Japan could prove to be a highly profitable market for the Company. NeutriSci expects to receive additional orders from Japan in the future and is confident that its TABLETZ products will succeed in Japan’s market.
NeutriSci International’s share price opened at $0.175, up from a previous close of $0.165. The Company’s shares are up 3.03% and are currently trading at $0.17 as of 12:07PM ET. This indicates that there has been some change following the news.